NYSE · Healthcare · Drug Manufacturers - General
Novo Nordisk A/S
NVO
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. CEO Maziar Mike Doustdar · Market cap $170.7B.
$38.45
+0.27 · +0.71%
52w hi $64.1652w lo $35.12
54
ROUTINE
Current InsiderScore
Corp · 90d
0
0 buys · 0 sales
Cong · 90d
4
2 buys · 2 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
No filings yet
No Form 4 filings on record. As the backfill progresses this will populate.
Section 02
Recent STOCK Act disclosures
4 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| Sep 25 | Kevin Hern | House · OK | Sell | $1,001 - $15,000 | $8K | 15 d | 44 |
| Sep 25 | Kevin Hern | House · OK | Sell | $1,001 - $15,000 | $8K | 25 d | 54 |
| Sep 18 | Scott Mr Franklin | House · FL | Buy | $1,001 - $15,000 | $8K | 23 d | 54 |
| Sep 18 | Scott Franklin | House · FL | Buy | $1,001 - $15,000 | $8K | 23 d | 54 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct